tiprankstipranks
Trending News
More News >
Lipigon Pharmaceuticals AB (DE:9RP)
FRANKFURT:9RP
Germany Market

Lipigon Pharmaceuticals AB (9RP) Income Statement

Compare
0 Followers

Lipigon Pharmaceuticals AB Income Statement

Last quarter (Q3 2024), Lipigon Pharmaceuticals AB's total revenue was kr0.00, a decrease of -100.00% from the same quarter last year. In Q3, Lipigon Pharmaceuticals AB's net income was kr-6.72M. See Lipigon Pharmaceuticals AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 10.29Mkr 16.41Mkr 390.00Kkr 3.18Mkr 4.28M
Gross Profit
kr -26.29Mkr -5.12Mkr 366.00Kkr -39.95Mkr -7.70M
Operating Expenses
kr 0.00kr 7.25Mkr 38.13Mkr 44.37Mkr 12.10M
Depreciation and Amortization
kr 59.00Kkr 24.00Kkr 24.00Kkr 23.00Kkr 7.82M
EBITDA
kr -25.14Mkr -12.10Mkr -37.68Mkr -41.09Mkr 0.00
Operating Income
kr -26.29Mkr -12.37Mkr -37.74Mkr -41.19Mkr -7.82M
Other Income/Expenses
kr 1.02Mkr 243.00Kkr 37.00Kkr 78.00Kkr -244.00K
Pretax Income
kr -25.26Mkr -12.13Mkr -37.70Mkr -41.11Mkr -8.07M
Net Income
kr -25.26Mkr -12.13Mkr -37.67Mkr -41.12Mkr -8.31M
Per Share Metrics
Basic EPS
kr -0.18kr -0.19kr -2.12kr -3.35kr -1.38
Diluted EPS
kr -0.18kr -0.19kr -2.12kr -3.35kr -1.38
Weighted Average Shares Outstanding
138.41M 64.12M 17.79M 12.27M 6.01M
Weighted Average Shares Outstanding (Diluted)
138.41M 64.12M 17.79M 12.27M 6.01M
Currency in SEK

Lipigon Pharmaceuticals AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis